TerminatedNot Applicable

Home Hospital for Lymphoma

Stopped: Study halted prematurely and will not resume due to poor accrual.

United States3 participantsStarted 2020-06-01

Plain-language summary

The goal of this research is to evaluate an intervention, which the investigators call "Home Hospital for Lymphoma," that involves remote patient monitoring and home-based supportive care for patients hospitalized with lymphoma at Massachusetts General Hospital.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 or older * Receiving their lymphoma care with curative intent at MGH (treatment intent based upon chemotherapy order in the electronic medical record) * Hemodynamically stable during the first 24 hours of hospital admission at MGH * Residing within the designated geographic area for MGH Home Hospital Service (an approximately 10-mile radius from MGH) * Able to communicate and respond to questionnaires in English * Lives with a family member or a friend who supports the patient at home * Deemed eligible for supportive oncology care at home based on the MGH Home Hospital clinician evaluation Exclusion Criteria: * Those admitted to the intensive care unit * Have high oxygen requirement (FIO2 \> 0.4) * Experience active angina or cardiac arrythmias * Have a planned inpatient surgical or interventional procedure * Have uncontrolled psychiatric illness or impaired cognition that prohibits complying with the study procedures * Have uncontrolled pain requiring intravenous pain medications * Those deemed ineligible based on the Home Hospital Service clinician evaluation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

enrollment rate

Timeframe: 1 year

retention rate

Timeframe: 1 year

Trial details

NCT IDNCT04423848

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-01-01

View on ClinicalTrials.gov More Lymphoma trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.